Mihop 50
Micafungin 50 mg Injection
| Packing | Vial Tray Pack |
|---|
Mihop 50 is a Micafungin 50 mg injectable antifungal product, which is an echinocandin antifungal medicine for use in a hospital setting under the supervision of a healthcare professional. Mihop 50 belongs to the group of drugs called Echinocandin antifungal drugs. It is available in the form of a vial tray pack.
Micafungin is administered in the treatment of certain fungal infections, including some strains of Candida species. It is a hospital-prescribed IV antifungal agent that could be used as a hospital medication under circumstances where IV antifungal is deemed to be necessary.
Mihop 50 Composition
Mihop 50 active pharmaceutical ingredient:
Micafungin – 50 mg
It is offered as an injection to be given into a vein. The Healthcare Professional should consult the approved Product Information before preparing or administering the product.
Micafungin interferes with the production of a key cell wall component, 1,3-beta-D-glucan, by working to block an enzyme complex that synthesises it.
This element is essential to the cellular structure of fungi. Micafungin is active by arresting the production of glucan and disrupting the cell wall of a fungal cell to give antifungal activity against fungi that are susceptible.
This mechanism establishes the position of micafungin in the echinocandin category of antifungal drugs that are most frequently administered in hospitals where IV antifungal treatment is required.
Micafungin injection is used to treat certain fungal infections when deemed appropriate by your healthcare provider. Approved uses for micafungin include infections due to certain types of fungus, such as Candida infections, including candidemia, other invasive candidiasis and esophageal candidiasis.
For certain patients at high risk of developing an invasive fungal infection, micafungin can also be prescribed for antifungal prophylaxis by indication and by adherence to the recommendations in the product information.
Mihop 50 should only be used according to the patient’s diagnosis, his condition, age, weight and other relevant considerations. The patient should be treated with antifungal medicine by a healthcare professional who will decide what the suspected or confirmed causative organism is.
It is given to the patient by the doctor through an injection. The doctor might also give this injection in the hospital to the patient, as it is an IV injectable medicine.
The vial should be reconstituted and diluted in accordance with the manufacturer’s instructions and the approved prescribing information. The rate of infusion and dosage depend on the indication and patient characteristics.
Do not, under any circumstances, self-medicate or give Mihop 50 to anyone else.
The prescribed dose of micafungin depends on the medical condition and individual factors. Various doses are prescribed for different fungal conditions.
Age, weight, severity of infection, immune status and general condition may be important factors in determining treatment. Thus, dosing and duration of therapy should be the responsibility of the prescribing physician rather than the manufacturer’s strength printed on the vial.
Health professionals must read the approved prescribing information before preparing or administering Mihop 50.
As with any other medicines, some people taking micafungin experience side effects. The list below mentions the effects that have been reported in patients using the medicine:
Some patients may develop hypersensitivity or other clinically significant reactions. In case of symptoms such as trouble breathing, swelling of the face or throat, extensive skin reactions or other serious symptoms, seek medical care.
This information can help the healthcare provider determine if the medication is the best option for treating the disease or condition.
Mihop 50 An Injectable prepared with Micafungin 50 mg Injection, an echinocandin antifungal medication used for certain fungal infections when prescribed by the doctor.
Micafungin can be used for some Candida infections such as candidemia, invasive candidiasis (infection that can spread from the bloodstream to other parts of the body), and esophageal candidiasis (infection in the esophagus). The use of this medication should be decided by a doctor.
No. Mihop 50 is an injection in the form of a powder for reconstitution and administration as an injection into the veins by the healthcare professional.
Micafungin is in the group of antifungal drugs called the echinocandins. It blocks the formation of 1,3-beta-D-glucan, which is needed to make the fungal cell wall.
Treatment with Mihop 50 shall be initiated under the close supervision and in an appropriate medical setting by a suitably qualified and experienced healthcare professional. The dose and duration of therapy should be determined by the indication.
+91 75081 05761
info@diyahealthcare.com
Plot No. 46, Near Passport Office Industrial Area, Phase 2 Chandigarh – 160002